In this study, we proposed ABCB1 methylation as a new valuable DNA methylation-based biomarker to stratify glioma patients according to the aggressiveness of the tumor, and to facilitate an accurate diagnosis and prognosis of gliomas. This evidence concerns the gene ABCB1 and glioma.